The Oncology Institute of Hope & Innovation Launches Oregon Market

TOI 09.30.2024

Full Press ReleaseSEC FilingsOur TOI Tweets

About Gravity Analytica

Recent News

  • 12.19.2024 - PRESS RELEASE: Florida Blue enhances cancer care for thousands of members
  • 12.18.2024 - Florida Blue enhances cancer care for thousands of members

Recent Filings

  • 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
  • 12.19.2024 - 8-K Current report
  • 12.06.2024 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
PDF Version

Anchor value-based payor partnership leads to opening of locations in Portland and Salem

CERRITOS, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, is proud to announce its expansion into Oregon with the opening of two new specialty cancer clinics. The clinic locations in Portland and Salem will mark TOI’s first capitated partnership in the market, with plans to expand to other markets in the state as additional partnerships develop. Both initial Oregon clinic locations will offer cutting edge cancer care services, offering a vital new option for patients in the Pacific Northwest.

“At TOI, we believe that every cancer patient deserves access to the most advanced care in their community,” said Dr. Dan Virnich, Chief Executive Officer of TOI. “We’re excited to bring a new cancer care option to Oregon residents that prioritizes optimal outcomes, patient satisfaction, and minimizing the financial burden often linked to cancer treatment, aligning with our mission and the needs of the community.”

Dr. Patan Gultawatvichai, Medical Director of TOI in Oregon, added, “TOI is redefining oncology care through our commitment to value-based care. I’m thrilled to lead and grow this model in Oregon. We are delighted to welcome the community and look forward to expanding our team with professionals who are dedicated to advancing the future of cancer care.”

About The Oncology Institute

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors

Solebury Strategic Communicationsinvestors@theoncologyinstitute.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com